# A Study of Mucopolysaccharidosis Type IIIB (MPS IIIB)

> **NCT02493998** · — · COMPLETED · sponsor: **Allievex Corporation** · enrollment: 22 (actual)

## Conditions studied

- Mucopolysaccharidosis Type IIIB
- Mucopolysaccharidosis Type 3 B
- MPS III B
- MPS 3 B

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT02493998
- **Lead sponsor:** Allievex Corporation
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2015-11
- **Primary completion:** 2019-04
- **Final completion:** 2019-04
- **Target enrollment:** 22 (ACTUAL)
- **Last updated:** 2020-03-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02493998

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02493998, "A Study of Mucopolysaccharidosis Type IIIB (MPS IIIB)". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT02493998. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*